The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
Novo Nordisk's oral semaglutide gets EU approval for heart related treatment of type 2 diabet
Alembic Pharmaceuticals receives EIR for API - I and API - II facility located at Panelav
CIDSCON 2025 emphasized a multi-faceted approach to tackle AMR
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes